Dec. 3 at 4:47 PM
$DMAC Congrats to
$CAPR C-suite and long bulls for an incredible step towards possible FDA treatment for DMD heart failure. My sell limit was surpassed at open, so bought back in with a starter. Now, preganant women with preeclampsia do not have a FDA approved treatment for preeclampsia.
$DMAC has been investigating rinvecalinase for many years. Currently, they are researching rinvecalinase, a recombinant form of an existing, natural form used in Asia, for acute ischemic stroke and preeclampsia. The natural procured form in Asia is costly to manufacture. The data seems favorable. Take a look. Always, let your DD be your guide.
